» Articles » PMID: 8692714

The Calcium Binding Protein Calretinin is a Selective Marker for Malignant Pleural Mesotheliomas of the Epithelial Type

Overview
Specialty Pathology
Date 1996 Feb 1
PMID 8692714
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

In a series of 23 cases of mesothelioma of either the epithelial, sarcomatoid or the mixed type, the expression of three calcium-binding proteins (calretinin, parvalbumin and calbindin-D28k) was studied using immunohistochemical techniques on paraffin sections. The results show that calretinin is expressed in mesotheliomas of the epithelial type (papillary, adenomatous or solid) and by the epithelial component of the mixed tumours. The immunohistochemical reaction is specific and reproducible. The tissues of the pulmonary parenchyma and of the pleura are negative for calretinin except for the rare fibroblasts and some skeletal muscle fibres situated in the interstices of, or near the epithelial tumour mass. The sarcomatoid mesotheliomas and the sarcomatoid component of the mixed tumours do not express calretinin. Parvalbumin and calbindin-D28k are expressed neither in mesotheliomas nor in normal lung tissue. Primary adenocarcinomas of the lung are negative for all three calcium binding proteins cited. Thus, calretinin seems to represent a selective marker for mesotheliomas of the epithelial type and allows their differentiation from metastases of lung adenocarcinomas.

Citing Articles

Composite Polycaprolactone/Gelatin Nanofiber Membrane Scaffolds for Mesothelial Cell Culture and Delivery in Mesothelium Repair.

Govindaraju D, Kao H, Chien Y, Chen J Int J Mol Sci. 2024; 25(18).

PMID: 39337295 PMC: 11432067. DOI: 10.3390/ijms25189803.


Detection of Carcinoma-Associated Fibroblasts Derived from Mesothelial Cells via Mesothelial-to-Mesenchymal Transition in Primary Ovarian Carcinomas.

Tomero-Sanz H, Jimenez-Heffernan J, Fernandez-Chacon M, Cristobal-Garcia I, Sainz de la Cuesta R, Gonzalez-Cortijo L Cancers (Basel). 2024; 16(15).

PMID: 39123425 PMC: 11311419. DOI: 10.3390/cancers16152697.


Pericardial malignant mesothelioma diagnosed in a dog by immunocytochemistry of the pericardial fluid: a case report.

Choi E BMC Vet Res. 2023; 19(1):89.

PMID: 37480011 PMC: 10362594. DOI: 10.1186/s12917-023-03655-8.


DNA repair and damage pathways in mesothelioma development and therapy.

Malakoti F, Targhazeh N, Abadifard E, Zarezadeh R, Samemaleki S, Asemi Z Cancer Cell Int. 2022; 22(1):176.

PMID: 35501851 PMC: 9063177. DOI: 10.1186/s12935-022-02597-9.


Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM).

Lapidot M, Case A, Larios D, Gandler H, Meng C, Tosic I Cancers (Basel). 2020; 13(1).

PMID: 33374980 PMC: 7792575. DOI: 10.3390/cancers13010007.